EndoChoice Holdings, Inc. Commo (NYSE:GI):
Harwood Feffer LLP Announces Investigation of EndoChoice Holdings, Inc..
The company is so far trading up by 88.39% since yesterday’s close of $4.22.
Company shares last traded at $7.95 which is marginally higher than the 50 day moving average of $4.09 and which is slightly above the 200 day moving average of $4.70. The 50 day moving average was up by +94.15% whereas the 200 day average was up by +69.26%.
As of the last earnings report the EPS was $-2.66 and is expected to be $-2.53 for the current year with 26,047,000 shares outstanding. Analysts expect next quarter’s EPS to be $-0.47 and the next full year EPS is anticipated to be $-1.43.
Several brokerage firms have released ratings on EndoChoice Holdings, Inc. Commo recently. Equity analyst JP Morgan released its first research report on the stock with a rating of “Overweight”. On March 24 the stock rating was downgraded from “Neutral” to “Underperform” in a report issued by Bank of America.
On March 4 Stifel Nicolaus kept the company rating at “Buy” but moved down the price target from $16.00 to $10.00. On June 30 analysts at William Blair started covering the stock by announcing an initial rating of “Outperform”.
JP Morgan began coverage giving it an initial rating of “Overweight” and projecting a price target of $26.00. On June 30, 2015 Stifel Nicolaus added GI to its research portfolio setting a rating of “Buy” and establishing a price target of $20.00.